Lactate dehydrogenase A (LDHA) inhibitor, GSK2837808A, Purity ≥98%

Synonym: 1445879-21-9; GSK 2837808A; GSK-2837808A; 3-[[3-(Cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl]amino]-5-(3,5-difluorophenoxy)benzoic acid; Lactate dehydrogenase A (LDHA) inhibitor

CAS Number: 1445879-21-9
Compound CID: 71533725

Product Size

2 mg; 5 mg; 10 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

GSK2837808A, soluble in DMSO and insoluble in water and ethanol, is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting lactate dehydrogenase A (LDHA). The molecular weight of the compound is 649.62, and its molecular formula is C₃₁H₂₅F₂N₅O₇S.

Molecular Weight

649.62

Molecular Formula

C₃₁H₂₅F₂N₅O₇S

Form

Lyophilized powder

Purity

≥98%

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Solubility

In vitro: DMSO: 93 mg/mL (143.15 mM); Water: insoluble; Ethanol: insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

GSK2837808A plays a key role in increasing insulin sensitivity and reducing body weight.